CORDIS
EU research results

CORDIS

English EN
European Initiative for basic research in Microbiology and Infectious Diseases - IAPP

European Initiative for basic research in Microbiology and Infectious Diseases - IAPP

Objective

The EIMID-IAPP training programme is part of the European Initiative for Basic Research in Microbiology and Infectious Diseases (EIMID), created in 2003 by scientists of five European centres of excellence (the Max Planck Institute for Infection Biology in Berlin, the CMMI at Imperial College in London, the Institut Pasteur in Paris, the Karolinska Institutet in Stockholm; and the vaccine company Novartis in Siena). By building a strong coalition among these institutes, EIMID aims at setting the basis for a future no-wall European Institute of Microbiology and Infectious Diseases, as part of the European Research Area (ERA). EIMID-IAPP aims at implementing the Industry-Academia cooperation through an integrated programme of exchange of young researchers between the industrial partner and the four academic institutions. The goal of the collaborative project is the development of Novel Therapeutic Approaches against Infectious Diseases, with particular emphasis to drug-based and vaccine-based therapies for bacterial infections affecting mucosal surfaces. Four researchers will be seconded from the industrial partner to the four academic institutions and vice-versa. Each secondment will be for two years (with a six month intermission for intermediate knowledge transfer to the mother institution), and the seconded staff between two institutions will investigate complementary aspects of the same project sub-area. Each institution will also recruit an experienced researcher for two years, to acquire new expertise and technologies necessary to the project development. A series of informal discussions, and annual general meetings, will allow constant exchange of information and efficient project steering. This activity of Industry-Academia exchange fulfils the EIMID goals of 1) harmonising European research programmes, so as to achieve a critical mass on relevant topics. 2) fostering exchange of scientists, particularly at the doctoral and post-doctoral levels.

Coordinator

GLAXOSMITHKLINE VACCINES SRL

Address

Via Fiorentina 1
53100 Siena

Italy

Activity type

Other

EU Contribution

€ 816 698

Administrative Contact

John Laird Telford (Dr.)

Participants (4)

Sort alphabetically

Sort by EU Contribution

Expand all

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

United Kingdom

EU Contribution

€ 346 501

INSTITUT PASTEUR

France

EU Contribution

€ 299 314

KAROLINSKA INSTITUTET

Sweden

EU Contribution

€ 357 062

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV

Germany

EU Contribution

€ 353 232

Project information

Grant agreement ID: 217768

Status

Closed project

  • Start date

    1 December 2008

  • End date

    30 November 2012

Funded under:

FP7-PEOPLE

  • Overall budget:

    € 2 172 806

  • EU contribution

    € 2 172 806

Coordinated by:

GLAXOSMITHKLINE VACCINES SRL

Italy